Literature DB >> 27875707

Mucormycosis Causing Ludwig Angina: A Unique Presentation.

Ryan P McSpadden1, James R Martin2, Swati Mehrotra3, Eric Thorpe4.   

Abstract

Mucormycosis is a rare fungal infection with a yearly incidence of 1.7 cases per million in the United States. It usually occurs in patients with metabolic abnormalities or who are immunocompromised with prolonged neutropenia. However, it can also occur in patients without any underlying disease process. The treatment of choice is surgical debridement of necrotic tissue and systemic antifungal therapy, including amphotericin B. A dilemma for the surgeon when faced with head and neck mucormycosis is the morbidity of surgical debridement from both a functional and cosmetic standpoint. There have been multiple case reports of a form of cutaneous mucormycosis in the head and neck involving the oral mucosa and the mandible, but no reports in the literature of a fungal infection causing Ludwig angina. This report describes one such case. The morbid clinical implications of mucormycosis causing Ludwig angina become apparent when considering the defect caused by adequate surgical debridement.
Copyright © 2016 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27875707     DOI: 10.1016/j.joms.2016.10.025

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  4 in total

1.  Rhinocerebral mucormycosis after functional endoscopic sinus surgery: A case report.

Authors:  Cha Dong Yeo; Jong Seung Kim; Sam Hyun Kwon; Eun Jung Lee; Min Hee Lee; Su Geun Kim; Yeon Seok You; June Sun Kim; Jong Hwan Lee; Ji Seob Ryu
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.889

2.  Neck infection after allogenic hematopoietic progenitors transplantation.

Authors:  J Mensa; C Dueñas Gutiérrez; C Cardozo; L Rodríguez Fernández; M Kestler; P Muñoz; E Bouza
Journal:  Rev Esp Quimioter       Date:  2020-02-14       Impact factor: 1.553

3.  Mucormycosis in COVID-19 pandemic: study at tertiary hospital in India.

Authors:  Reshma P Chavan; Shivraj M Ingole; Hamna Abdul Nazir; Wilson V Desai; Gajanan S Kanchewad
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-02-05       Impact factor: 3.236

4.  Mucormycosis of jaws - literature review and current treatment protocols.

Authors:  Hitesh Dewan; Hiren Patel; Haren Pandya; Bijal Bhavsar; Urvi Shah; Surya Singh
Journal:  Natl J Maxillofac Surg       Date:  2022-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.